ChengDu ShengNuo Biotec Co.,Ltd. (688117.SS)

CNY 27.72

(0.84%)

Total Assets Summary of ChengDu ShengNuo Biotec Co.,Ltd.

  • ChengDu ShengNuo Biotec Co.,Ltd.'s latest annual total assets in 2023 was 1.31 Billion CNY , up 18.75% from previous year.
  • ChengDu ShengNuo Biotec Co.,Ltd.'s latest quarterly total assets in 2024 Q3 was 1.52 Billion CNY , up 4.49% from previous quarter.
  • ChengDu ShengNuo Biotec Co.,Ltd. reported annual total assets of 1.1 Billion CNY in 2022, up 15.83% from previous year.
  • ChengDu ShengNuo Biotec Co.,Ltd. reported annual total assets of 956.61 Million CNY in 2021, up 61.32% from previous year.
  • ChengDu ShengNuo Biotec Co.,Ltd. reported quarterly total assets of 1.35 Billion CNY for 2024 Q1, up 2.97% from previous quarter.
  • ChengDu ShengNuo Biotec Co.,Ltd. reported quarterly total assets of 1.52 Billion CNY for 2024 Q3, up 4.49% from previous quarter.

Annual Total Assets Chart of ChengDu ShengNuo Biotec Co.,Ltd. (2023 - 2017)

Historical Annual Total Assets of ChengDu ShengNuo Biotec Co.,Ltd. (2023 - 2017)

Year Total Assets Total Assets Growth
2023 1.31 Billion CNY 18.75%
2022 1.1 Billion CNY 15.83%
2021 956.61 Million CNY 61.32%
2020 592.98 Million CNY 14.27%
2019 518.92 Million CNY 8.5%
2018 478.25 Million CNY 37.35%
2017 348.19 Million CNY 0.0%

Peer Total Assets Comparison of ChengDu ShengNuo Biotec Co.,Ltd.

Name Total Assets Total Assets Difference
Hubei Jumpcan Pharmaceutical Co., Ltd. 18.14 Billion CNY 92.748%
Yabao Pharmaceutical Group Co., Ltd 3.85 Billion CNY 65.858%
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited 78.58 Billion CNY 98.326%
Harbin Pharmaceutical Group Co., Ltd. 14.11 Billion CNY 90.677%
Tasly Pharmaceutical Group Co., Ltd 16.71 Billion CNY 92.128%
Zhejiang Medicine Co., Ltd. 12.77 Billion CNY 89.704%
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited 10.23 Billion CNY 87.139%
Lionco Pharmaceutical Group Co.,Ltd. 1.62 Billion CNY 19.01%
Humanwell Healthcare (Group) Co.,Ltd. 36.2 Billion CNY 96.366%
Ginwa Enterprise (Group) Inc. 2.1 Billion CNY 37.601%
Joincare Pharmaceutical Group Industry Co.,Ltd. 36.35 Billion CNY 96.381%
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. 2.17 Billion CNY 39.376%
China Animal Husbandry Industry Co., Ltd. 8.94 Billion CNY 85.293%
Jiangsu Jibeier Pharmaceutical Co., Ltd. 2.2 Billion CNY 40.456%
Zhejiang Huahai Pharmaceutical Co., Ltd. 18.59 Billion CNY 92.926%
Shanghai Haoyuan Chemexpress Co., Ltd. 4.19 Billion CNY 68.615%
Ningbo Menovo Pharmaceutical Co., Ltd. 4.42 Billion CNY 70.256%
Zhejiang Jiuzhou Pharmaceutical Co., Ltd 10.85 Billion CNY 87.876%
Chongqing Taiji Industry(Group) Co.,Ltd 14.41 Billion CNY 90.87%
HPGC Renmintongtai Pharmaceutical Corporation 7.42 Billion CNY 82.283%
Nanjing Well Pharmaceutical Group Co.,Ltd. 2.27 Billion CNY 42.265%
Tianjin Tianyao Pharmaceuticals Co., Ltd. 6.14 Billion CNY 78.58%
Henan Lingrui Pharmaceutical Co., Ltd. 4.77 Billion CNY 72.428%
Shenzhen Chipscreen Biosciences Co., Ltd. 3.2 Billion CNY 58.925%
Guizhou Yibai Pharmaceutical Co., Ltd. 4.78 Billion CNY 72.476%
Jiangsu Kanion Pharmaceutical Co.,Ltd. 7.11 Billion CNY 81.514%
Zhongzhu Healthcare Holding Co.,Ltd 3.01 Billion CNY 56.416%
Beijing Tongrentang Co., Ltd 30.08 Billion CNY 95.627%
KPC Pharmaceuticals, Inc. 9.59 Billion CNY 86.282%
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. 2.87 Billion CNY 54.262%
North China Pharmaceutical Company Ltd. 20.95 Billion CNY 93.722%
China Resources Double-Crane Pharmaceutical Co.,Ltd. 15.49 Billion CNY 91.51%
Tibet Weixinkang Medicine Co., Ltd. 1.77 Billion CNY 25.954%
China National Medicines Corporation Ltd. 32.45 Billion CNY 95.946%
Zhejiang Hisun Pharmaceutical Co., Ltd. 17.61 Billion CNY 92.53%
Heilongjiang ZBD Pharmaceutical Co., Ltd. 12.46 Billion CNY 89.445%
Dali Pharmaceuticalco.,Ltd 473.83 Million CNY -177.676%
Changchun BCHT Biotechnology Co. 5.04 Billion CNY 73.927%
Zhejiang Shengda Bio-Pharm Co., Ltd. 1.71 Billion CNY 23.468%
Shanghai Jiaoda Onlly Co.,Ltd 815.09 Million CNY -61.42%
Jiang Zhong Pharmaceutical Co.,Ltd 6.12 Billion CNY 78.531%
Mayinglong Pharmaceutical Group Co., LTD. 4.82 Billion CNY 72.757%
Cisen Pharmaceutical Co., Ltd. 7.33 Billion CNY 82.069%
Hunan Warrant Pharmaceutical Co.,Ltd 2.17 Billion CNY 39.561%
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. 114.03 Billion CNY 98.846%
Jianmin Pharmaceutical Group Co.,Ltd. 4.16 Billion CNY 68.432%
Hunan Fangsheng Pharmaceutical Co., Ltd. 3.08 Billion CNY 57.295%
Guangxi Wuzhou Zhongheng Group Co.,Ltd 11.66 Billion CNY 88.722%
Guobang Pharma Ltd. 10.36 Billion CNY 87.302%
Shaanxi Kanghui Pharmaceutical Co., Ltd. 2.05 Billion CNY 35.872%
Kangmei Pharmaceutical Co., Ltd. 14.28 Billion CNY 90.786%
Shandong Buchang Pharmaceuticals Co., Ltd. 20.89 Billion CNY 93.702%
Zhejiang Starry Pharmaceutical Co.,Ltd. 5.51 Billion CNY 76.159%
Henan Taloph Pharmaceutical Stock Co.,Ltd 3.57 Billion CNY 63.216%
ZhuZhou QianJin Pharmaceutical Co.,Ltd 4.67 Billion CNY 71.867%
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd 9.52 Billion CNY 86.186%
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. 1.86 Billion CNY 29.377%
Shanghai Shyndec Pharmaceutical Co., Ltd. 19.35 Billion CNY 93.201%
Shanghai Yizhong Pharmaceutical Co., Ltd. 1.57 Billion CNY 16.375%
Tibet Rhodiola Pharmaceutical Holding Co. 4.58 Billion CNY 71.318%
Sichuan Huiyu Pharmaceutical Co., Ltd. 4.68 Billion CNY 71.92%
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. 1.89 Billion CNY 30.487%
CanSino Biologics Inc. 9.36 Billion CNY 85.958%
Jiangsu Lianhuan Pharmaceutical Co., Ltd. 2.85 Billion CNY 53.926%
Shandong Lukang Pharmaceutical Co.,Ltd. 8.8 Billion CNY 85.053%